You could have triangulated
this with price action in commodity and emerging markets to either help you to side - step or go outright short into what became a nasty bear market.
Too put trading
with price action in the context of a sales metaphor; you are cutting out the middle - man and buying directly from the producer.
i work
with price action in the daily chart for big operation — minimum 100 pips each — and also intrady with the 15m time frame for multi small 20 pips each — .
Not exact matches
Important factors that could cause actual results to differ materially from those reflected
in such forward - looking statements and that should be considered
in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions
with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases
in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest
in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions
in the industries and markets
in which we operate
in the U.S. and globally and any changes therein, including fluctuations
in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain
in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future
pricing under our supply agreements
with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements
with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts
with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase
price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both
in the U.S. and abroad; 20) the effect of changes
in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction
in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships
with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory
actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco
in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations
in foreign current exchange rates, impositions of tariffs or embargoes, compliance
with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
As
with previous examples, the
action has been mainly
in financial assets
with real estate
prices soaring
in the financial centres.
Some foreign investors, rather than crunching data on earnings and stock valuations to come up
with investment strategies, actively mimicked the
actions of China's so - called «national team» — a group of state - backed financial institutions that were tasked
with propping up share
prices in the height of the market rout.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth
in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures
in European countries that may increase the amount of discount required on Gilead's products; an increase
in discounts, chargebacks and rebates due to ongoing contracts and future negotiations
with commercial and government payers; a larger than anticipated shift
in payer mix to more highly discounted payer segments and geographic regions and decreases
in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations
in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations
in Gilead's earnings; market share and
price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government
action that could have the effect of lowering
prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials
in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations
in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates
in the timelines currently anticipated; Gilead's ability to receive regulatory approvals
in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta
in combination
with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes
in its stock
price, corporate or other market conditions; fluctuations
in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time
in Gilead's reports filed
with the U.S. Securities and Exchange Commission (the SEC).
In no case, except due to an adjustment to reflect a stock split or other event referred to under «Adjustments» below, and except for any repricing that may be approved by shareholders, will the plan administrator (1) amend an outstanding stock option or stock appreciation right to reduce the exercise price or base price of the award, (2) cancel, exchange, or surrender an outstanding stock option or stock appreciation right in exchange for cash or other awards for the purpose of repricing the award, (3) cancel, exchange, or surrender an outstanding stock option or stock appreciation right in exchange for an option or stock appreciation right with an exercise or base price that is less than the exercise or base price of the original award, or (4) take any other action that is treated as a repricing under U.S. generally accepted accounting principle
In no case, except due to an adjustment to reflect a stock split or other event referred to under «Adjustments» below, and except for any repricing that may be approved by shareholders, will the plan administrator (1) amend an outstanding stock option or stock appreciation right to reduce the exercise
price or base
price of the award, (2) cancel, exchange, or surrender an outstanding stock option or stock appreciation right
in exchange for cash or other awards for the purpose of repricing the award, (3) cancel, exchange, or surrender an outstanding stock option or stock appreciation right in exchange for an option or stock appreciation right with an exercise or base price that is less than the exercise or base price of the original award, or (4) take any other action that is treated as a repricing under U.S. generally accepted accounting principle
in exchange for cash or other awards for the purpose of repricing the award, (3) cancel, exchange, or surrender an outstanding stock option or stock appreciation right
in exchange for an option or stock appreciation right with an exercise or base price that is less than the exercise or base price of the original award, or (4) take any other action that is treated as a repricing under U.S. generally accepted accounting principle
in exchange for an option or stock appreciation right
with an exercise or base
price that is less than the exercise or base
price of the original award, or (4) take any other
action that is treated as a repricing under U.S. generally accepted accounting principles.
During the 1980s, the Mulroney Government released economic and fiscal updates,
with policy
actions,
in reaction to dramatic falls
in grain and oil
prices.
Over the past few weeks,
price action has been quiet and volatility has been low,
with the
price trading
in a tight range near the highs of the base:
Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and
price effectively and develop and maintain good relationships
with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including
with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes
in existing laws or regulations; the outcome of litigation, regulatory audits, investigations,
actions and / or guaranty fund assessments; uncertainties surrounding participation
in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated
with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed
in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.
While this week's
price action was certainly a step
in the right direction (so far), both the NASDAQ and Russell 2000 are now
in «no man's land» because the indexes are back above resistance of their 20 and 50 - day averages, yet still must contend
with resistance of their prior highs and short - term downtrend lines that have formed.
With higher oil
prices and the efficiency
actions they have taken,
in my opinion, RDS is going
in the right direction!
An analyst
with Marketwatch points out that Apple's stock
price action has produced a «death cross»,
in which the 50 day moving average crosses below the 200 day moving average.
With the strong move off the July 2012 low, the
price action of FXE should continue to consolidate
in a tight range, and ideally not retrace more than 38 % of the rally from the July 27 low to September 14 high.
In the chart below, we are going to look at a particularly good
price action signal for trading
with trends; the inside bar strategy.
With much of the
price action in gold driven by sentiment and technical analysis, you should keep an eye on the broader trends, even if you consider yourself a buy - and - hold investor.
We view these comments as the true culprit
in today's
price action when coupled
with a reduction
in trade war fears.
Combining my
price action strategies
with sound capital preservation and risk management skills has enabled me to stay
in the game for 12 years.
Important factors that may affect the Company's business and operations and that may cause actual results to differ materially from those
in the forward - looking statements include, but are not limited to, increased competition; the Company's ability to maintain, extend and expand its reputation and brand image; the Company's ability to differentiate its products from other brands; the consolidation of retail customers; the Company's ability to predict, identify and interpret changes
in consumer preferences and demand; the Company's ability to drive revenue growth
in its key product categories, increase its market share, or add products; an impairment of the carrying value of goodwill or other indefinite - lived intangible assets; volatility
in commodity, energy and other input costs; changes
in the Company's management team or other key personnel; the Company's inability to realize the anticipated benefits from the Company's cost savings initiatives; changes
in relationships
with significant customers and suppliers; execution of the Company's international expansion strategy; changes
in laws and regulations; legal claims or other regulatory enforcement
actions; product recalls or product liability claims; unanticipated business disruptions; failure to successfully integrate the Company; the Company's ability to complete or realize the benefits from potential and completed acquisitions, alliances, divestitures or joint ventures; economic and political conditions
in the nations
in which the Company operates; the volatility of capital markets; increased pension, labor and people - related expenses; volatility
in the market value of all or a portion of the derivatives that the Company uses; exchange rate fluctuations; disruptions
in information technology networks and systems; the Company's inability to protect intellectual property rights; impacts of natural events
in the locations
in which the Company or its customers, suppliers or regulators operate; the Company's indebtedness and ability to pay such indebtedness; the Company's dividend payments on its Series A Preferred Stock; tax law changes or interpretations;
pricing actions; and other factors.
In hindsight these setup outputs look easy and straightforward, the reality is that in the moment of actual price action traders deal with high levels of uncertainty and this, in particular, is where Mella outlines levels of patience and keeping her members psychologically focuse
In hindsight these setup outputs look easy and straightforward, the reality is that
in the moment of actual price action traders deal with high levels of uncertainty and this, in particular, is where Mella outlines levels of patience and keeping her members psychologically focuse
in the moment of actual
price action traders deal
with high levels of uncertainty and this,
in particular, is where Mella outlines levels of patience and keeping her members psychologically focuse
in particular, is where Mella outlines levels of patience and keeping her members psychologically focused.
Traders can watch the 66.55 — 64.25 support range this week for
price action buy signals to get long,
in - line
with the uptrend.
«Bitcoin
price staged a strong rally to break past the short - term channel top and aim for the longer - term resistance... Buyers are taking control of bitcoin
price action... Moving averages are
in line
with the 4 - hour bullish channel support at $ 610, adding to its strength as a floor.
As
with $ YCS above, $ PALL was volatile and marked by wide swings
in the first few months it attempted to build a base of consolidation, but the
price action of this palladium ETF has been contracting since July:
«Yes it is absolutely a reaction — there were mistakes made
with respect to helping people understand why we took this
action, I think that it makes sense to lower the
price in response to the anger that was felt by people,» Shkreli, 32, said.
When indecision and choppy
price action starts appearing after an extended rally, it is often a warning sign that a substantial pullback may be just around the corner (especially when combined
with higher volume selling
in the broad -LSB-...]
In my previous blog post, I said that indecision and choppy price action near the highs «is often a warning sign that a substantial pullback may be just around the c orner (especially when combined with higher volume selling in the broad market).&raqu
In my previous blog post, I said that indecision and choppy
price action near the highs «is often a warning sign that a substantial pullback may be just around the c orner (especially when combined
with higher volume selling
in the broad market).&raqu
in the broad market).»
In my previous blog post, I said that indecision and choppy price action near the highs «is often a warning sign that a substantial pullback may be just around the corner (especially when combined with higher volume selling in the broad market).&raqu
In my previous blog post, I said that indecision and choppy
price action near the highs «is often a warning sign that a substantial pullback may be just around the corner (especially when combined
with higher volume selling
in the broad market).&raqu
in the broad market).»
Quarter - ending sessions are always tricky affairs
in stocks, as funds are adjusting their holdings, all forms of
price triggers affect the market, and generally, unusual
price action is to be expected,
with assets showing strength and weakness out of the blue, especially around major
price levels.
In the event of a change of control (as defined in the plan), the compensation committee may, in its discretion, provide for any or all of the following actions: (i) awards may be continued, assumed, or substituted with new rights, (ii) awards may be purchased for cash equal to the excess (if any) of the highest price per share of common stock paid in the change in control transaction over the aggregate exercise price of such awards, (iii) outstanding and unexercised stock options and stock appreciation rights may be terminated, prior to the change in control (in which case holders of such unvested awards would be given notice and the opportunity to exercise such awards), or (iv) vesting or lapse of restrictions may be accelerate
In the event of a change of control (as defined
in the plan), the compensation committee may, in its discretion, provide for any or all of the following actions: (i) awards may be continued, assumed, or substituted with new rights, (ii) awards may be purchased for cash equal to the excess (if any) of the highest price per share of common stock paid in the change in control transaction over the aggregate exercise price of such awards, (iii) outstanding and unexercised stock options and stock appreciation rights may be terminated, prior to the change in control (in which case holders of such unvested awards would be given notice and the opportunity to exercise such awards), or (iv) vesting or lapse of restrictions may be accelerate
in the plan), the compensation committee may,
in its discretion, provide for any or all of the following actions: (i) awards may be continued, assumed, or substituted with new rights, (ii) awards may be purchased for cash equal to the excess (if any) of the highest price per share of common stock paid in the change in control transaction over the aggregate exercise price of such awards, (iii) outstanding and unexercised stock options and stock appreciation rights may be terminated, prior to the change in control (in which case holders of such unvested awards would be given notice and the opportunity to exercise such awards), or (iv) vesting or lapse of restrictions may be accelerate
in its discretion, provide for any or all of the following
actions: (i) awards may be continued, assumed, or substituted
with new rights, (ii) awards may be purchased for cash equal to the excess (if any) of the highest
price per share of common stock paid
in the change in control transaction over the aggregate exercise price of such awards, (iii) outstanding and unexercised stock options and stock appreciation rights may be terminated, prior to the change in control (in which case holders of such unvested awards would be given notice and the opportunity to exercise such awards), or (iv) vesting or lapse of restrictions may be accelerate
in the change
in control transaction over the aggregate exercise price of such awards, (iii) outstanding and unexercised stock options and stock appreciation rights may be terminated, prior to the change in control (in which case holders of such unvested awards would be given notice and the opportunity to exercise such awards), or (iv) vesting or lapse of restrictions may be accelerate
in control transaction over the aggregate exercise
price of such awards, (iii) outstanding and unexercised stock options and stock appreciation rights may be terminated, prior to the change
in control (in which case holders of such unvested awards would be given notice and the opportunity to exercise such awards), or (iv) vesting or lapse of restrictions may be accelerate
in control (
in which case holders of such unvested awards would be given notice and the opportunity to exercise such awards), or (iv) vesting or lapse of restrictions may be accelerate
in which case holders of such unvested awards would be given notice and the opportunity to exercise such awards), or (iv) vesting or lapse of restrictions may be accelerated.
Many factors could cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current products and services, or develop new products and services
in a timely manner or at competitive
prices, including risks related to new product introductions; risks related to BlackBerry's ability to mitigate the impact of the anticipated decline
in BlackBerry's infrastructure access fees on its consolidated revenue by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated
with BlackBerry's foreign operations, including risks related to recent political and economic developments
in Venezuela and the impact of foreign currency restrictions; risks relating to network disruptions and other business interruptions, including costs, potential liabilities, lost revenues and reputational damage associated
with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits of its CORE program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry ® World ™; risks related to the collection, storage, transmission, use and disclosure of confidential and personal information; BlackBerry's ability to manage inventory and asset risk; BlackBerry's reliance on suppliers of functional components for its products and risks relating to its supply chain; BlackBerry's ability to obtain rights to use software or components supplied by third parties; BlackBerry's ability to successfully maintain and enhance its brand; risks related to government regulations, including regulations relating to encryption technology; BlackBerry's ability to continue to adapt to recent board and management changes and headcount reductions; reliance on strategic alliances
with third - party network infrastructure developers, software platform vendors and service platform vendors; BlackBerry's reliance on third - party manufacturers; potential defects and vulnerabilities
in BlackBerry's products; risks related to litigation, including litigation claims arising from BlackBerry's practice of providing forward - looking guidance; potential charges relating to the impairment of intangible assets recorded on BlackBerry's balance sheet; risks as a result of
actions of activist shareholders; government regulation of wireless spectrum and radio frequencies; risks related to economic and geopolitical conditions; risks associated
with acquisitions; foreign exchange risks; and difficulties
in forecasting BlackBerry's financial results given the rapid technological changes, evolving industry standards, intense competition and short product life cycles that characterize the wireless communications industry.
«Given the position bias for flattening, periodic steepening corrections should be expected but don't signal a change
in view, but rather a case of ringing the register after which there will attempts to justify the
price action with something more cerebral until we revert to flattening.»
When you have a strong entry method, like
price action setups, combined
with an understanding of risk to reward scenarios you begin to think
in probabilities.
Real estate
prices experienced similar manic
action,
with prices in Tokyo's prime neighborhoods rising to levels that made them 350 times more expensive than comparable land
in Manhattan, New York (Investopedia, 2010).
Price action trading is used
in lots of situations, and for you to use it well, it is important to familiarize yourself
with candle stick Graphs.
The relative strength line finally confirms the
price action here, as the line has moved
in step
with the
price action and has actually outperformed, making a «higher high» at point «C» ahead of the
price.
Although this implies that a short - term recovery is
in play,
price action remains extremely weak,
with the 2o - day and 50 - day simple moving averages trending firmly lower.
This triggered the study below that examined similar
price action in SPY
with regards to how it gapped and finished
In this way,
price action is truly the best method to learn how to trade
with.
If you take my Forex trading course and join my members» community, not only will I share
with you all of my professional trading knowledge and strategies, but
in my opinion you are getting taught the most relevant and consistently effective way to trade the markets, which is without doubt,
Price action analysis.
As usual, I don't place too much emphasis on this sort of forecast, but to the extent that I make any comments at all about the outlook for 2006, the bottom line is this: 1) we can't rule out modest potential for stock appreciation, which would require the maintenance or expansion of already high
price / peak earnings multiples; 2) we also should recognize an uncomfortably large potential for market losses, particularly given that the current bull market has now outlived the median and average bull, yet at higher valuations than most bulls have achieved, a flat yield curve
with rising interest rate pressures, an extended period of internal divergence as measured by breadth and other market
action, and complacency at best and excessive bullishness at worst, as measured by various sentiment indicators; 3) there is a moderate but still not compelling risk of an oncoming recession, which would become more of a factor if we observe a substantial widening of credit spreads and weakness
in the ISM Purchasing Managers Index
in the months ahead, and; 4) there remains substantial potential for U.S. dollar weakness coupled
with «unexpectedly» persistent inflation pressures, particularly if we do observe economic weakness.
I have always agreed
with you that
price action method of trading is the best strategy
in the forex market because I have always spent time to examine that.
This video describes that Momentum is a situation when market sentiment is moving
in one direction
with high volume, this is derived from
price action.
Thanks Nial for your wonderful lesson.I keep imroving
in my trading since I started following your
price action strategies.Please keep up
with the good job.Posterity, no doubt has a huge place for your CALIBRE
in FX annals.Always keep me posted
with the latest from your educative stable.
Higher
prices, fewer foreclosures and competition from funds
with deep pockets have had an impact on investors»
actions in the marketplace over the past eight months.
Here is an example of pure
price action trading
in the GBPUSD
with some of my favorite
price action setups:
RYE, NEW HAMPSHIRE, U.S.A., Monday, Feb. 8, 1999 — The Gold Anti-Trust
Action Committee has formally incorporated itself
in Delaware and has begun negotiating
with law firms interested
in undertaking its lawsuit against the Wall Street investment houses it accuses of illegal collusion to control the
price and supply of gold, other commodities, and certain related financial securities.
The fear of a peak earnings cycle surfaced
with this headline and certainly
with Apple being such a huge component (14.60 % of the Nasdaq 100), its stock
price action carries a lot of sway as to the investor sentiment
in the tech sector.
In this way, the lead is nurtured until they indicate that they are ready to make a purchasing decision by completing high - level
actions like viewing your
pricing pages, requesting a free demo, and interacting
with your content more frequently.
Friday i traded gbp - usd, eur - jpy and gbp - jpy too because if u check the daily chart u can se one more
price action set up
in the main trend direction (i trade
price action only
with trend, never counter trend).